Non-invasive detection of orthotopic human lung tumors by microRNA expression profiling of mouse exhaled breath condensates and exhaled extracellular vesicles

Abstract

Aim: The lung is the second most frequent site of metastatic dissemination. Early detection is key to improving survival. Given that the lung interfaces with the external environment, the collection of exhaled breath condensate (EBC) provides the opportunity to obtain biological material including exhaled miRNAs that originate from the lung.

Methods: In this proof-of-principal study, we used the highly metastatic MDA-MB-231 subline 3475 breast cancer cell line (LM-3475) to establish an orthotopic lung tumor-bearing mouse model and investigate non-invasive detection of lung tumors by analysis of exhaled miRNAs. We initially conducted miRNA NGS and qPCR validation analyses on condensates collected from unrestrained animals and identified significant miRNA expression differences between the condensates of lung tumor-bearing and control mice. To focus our purification of EBC and evaluate the origin of these differentially expressed miRNAs, we developed a system to collect EBC directly from the nose and mouth of our mice.

Results: Using nanoparticle distribution analyses, TEM, and ONi super-resolution nanoimaging, we determined that human tumor EVs could be increasingly detected in mouse EBC during the progression of secondary lung tumors. Using our customizable EV-CATCHER assay, we purified human tumor EVs from mouse EBC and demonstrated that the bulk of differentially expressed exhaled miRNAs originate from lung tumors, which could be detected by qPCR within 1 to 2 weeks after tail vein injection of the metastatic cells.

Conclusion: This study is the first of its kind and demonstrates that lung tumor EVs are exhaled in mice and provide non-invasive biomarkers for detection of lung tumors.

Keywords

Extracellular vesicles / exhaled breath condensate / orthotopic lung tumor-bearing animal model / miRNAs

References

[1] Sung H,Siegel RL.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2021;71:209-49

[2] Siegel RL,Fuchs HE.Cancer statistics, 2021.CA Cancer J Clin2021;71:7-33

[3] Stella GM,Benvenuti S.Lung-seeking metastases.Cancers2019;11:1010 PMCID:PMC6678078

[4] Caparica R,Rocha CH.Pulmonary nodules in patients with nonpulmonary cancer: not always metastases.J Glob Oncol2016;2:138-44 PMCID:PMC5495454

[5] Chen H,Lehrer EJ.The epidemiology of lung metastases.Front Med2021;8:723396 PMCID:PMC8488106

[6] Ha D,Chevalier C,Wang XF.Survival in patients with metachronous second primary lung cancer.Ann Am Thorac Soc2015;12:79-84

[7] Jamil A. and Kasi A. Lung metastasis. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553111/ [Last accessed on 27 Mar 2024]

[8] Wang R,Liu L.Second primary lung cancer after breast cancer: a population-based study of 6,269 women.Front Oncol2018;8:427 PMCID:PMC6189405

[9] Medeiros B.Molecular mechanisms of breast cancer metastasis to the lung: clinical and experimental perspectives.Int J Mol Sci2019;20:2272 PMCID:PMC6540248

[10] Mangiameli G,Alloisio M.Lung metastases: current surgical indications and new perspectives.Front Surg2022;9:884915 PMCID:PMC9098997

[11] Antonoff MB,Callstrom MR.The roles of surgery, stereotactic radiation, and ablation for treatment of pulmonary metastases.J Thorac Cardiovasc Surg2022;163:495-502

[12] Dama E,Fina E.Biomarkers and lung cancer early detection: state of the art.Cancers2021;13:3919 PMCID:PMC8345487

[13] Haranguș A,Todea DA,Șimon M.Noncoding RNAs and liquid biopsy in lung cancer: a literature review.Diagnostics2019;9:216 PMCID:PMC6963838

[14] de Fraipont F,Cho WC.Circular RNAs and RNA splice variants as biomarkers for prognosis and therapeutic response in the liquid biopsies of lung cancer patients.Front Genet2019;10:390 PMCID:PMC6514155

[15] Zhong S,Zardo P.miRNAs in lung cancer. a systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer.Transl Res2021;230:164-96

[16] Patel U,Allan AL.Influence of extracellular vesicles on lung stromal cells during breast cancer metastasis.Int J Mol Sci2023;24:11801 PMCID:PMC10380344

[17] Hinestrosa JP,Lewis JM.Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test.Commun Med2022;2:29 PMCID:PMC9053211

[18] Liu Z,Dang Q.Liquid biopsy in pre-metastatic niche: from molecular mechanism to clinical application.Front Immunol2022;13:958360 PMCID:PMC9334814

[19] Habli Z,Saab R,Khraiche ML.Circulating tumor cell detection technologies and clinical utility: challenges and opportunities.Cancers2020;12:1930 PMCID:PMC7409125

[20] Agashe R.Circulating tumor cells: from the laboratory to the cancer clinic.Cancers2020;12:2361 PMCID:PMC7564158

[21] Pantel K.Circulating tumour cells in cancer patients: challenges and perspectives.Trends Mol Med2010;16:398-406

[22] Riethdorf S,Müller V.Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.Clin Cancer Res2007;13:920-8

[23] Seijo LM,Ajona D.Biomarkers in lung cancer screening: achievements, promises, and challenges.J Thorac Oncol2019;14:343-57 PMCID:PMC6494979

[24] Yendamuri S,Zaidi T.3p and 10q deletions detected by fluorescence in situ hybridization (FISH): A potential new tool for early detection of non-small cell lung cancer (NSCLC).J Clin Oncol2007;25:7606

[25] Chen CC,Lee KY,Pan ST.Evaluation of the diagnostic accuracy of bronchial brushing cytology in lung cancer: A meta-analysis.Cancer Cytopathol2021;129:739-49

[26] Pavel AB,Liu G.AEGIS Study TeamAlterations in bronchial airway miRNA expression for lung cancer detection.Cancer Prev Res2017;10:651-9 PMCID:PMC6758560

[27] Matthiesen R.MS-based biomarker discovery in bronchoalveolar lavage fluid for lung cancer.Proteomics Clin Appl2020;14:e1900077

[28] Engel E,Carstensen T.Detection of tumor-specific mRNA in cell-free bronchial lavage supernatant in patients with lung cancer.Ann N Y Acad Sci2004;1022:140-6

[29] Anglim PP,Laird-Offringa IA.DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update.Mol Cancer2008;7:81 PMCID:PMC2585582

[30] Schmidt B,Fleischhacker M. Liquid profiling in lung cancer - quantification of extracellular mirnas in bronchial lavage. In: Gahan PB, Fleischhacker M, Schmidt B, editors. Circulating Nucleic Acids in Serum and Plasma - CNAPS IX. Cham: Springer International Publishing; 2016. pp. 33-7.

[31] Mutlu GM,Robbins RA,Rubinstein I.Collection and analysis of exhaled breath condensate in humans.Am J Respir Crit Care Med2001;164:731-7

[32] Keogh RJ.The use of breath analysis in the management of lung cancer: is it ready for primetime?.Curr Oncol2022;29:7355-78 PMCID:PMC9600994

[33] Wang P,Meng S.Identification of lung cancer breath biomarkers based on perioperative breathomics testing: a prospective observational study.EClinicalMedicine2022;47:101384 PMCID:PMC9035731

[34] van der Schee M,Gaude E.Breath biopsy for early detection and precision medicine in cancer.Ecancermedicalscience2018;12:ed84 PMCID:PMC6070367

[35] Marzorati D,Sedda G,Spaggiari L.A review of exhaled breath: a key role in lung cancer diagnosis.J Breath Res2019;13:034001

[36] Jia Z,Kutty VK.Critical review of volatile organic compound analysis in breath and in vitro cell culture for detection of lung cancer.Metabolites2019;9:52 PMCID:PMC6468373

[37] Kubáň P.Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review.Anal Chim Acta2013;805:1-18

[38] Rahimpour E,Jouyban-Gharamaleki V.Non-volatile compounds in exhaled breath condensate: review of methodological aspects.Anal Bioanal Chem2018;410:6411-40

[39] Campanella A,Tommasi S.Exhaled breath condensate biomarkers for lung cancer.J Breath Res2019;13:044002

[40] Effros RM,Casaburi R.Epithelial lining fluid solute concentrations in chronic obstructive lung disease patients and normal subjects.J Appl Physiol2005;99:1286-92

[41] Horváth I,Barnes PJ.ATS/ERS Task Force on Exhaled Breath CondensateExhaled breath condensate: methodological recommendations and unresolved questions.Eur Respir J2005;26:523-48

[42] Kuo TC,Wang SY.Human breathomics database.Database2020;2020:baz139 PMCID:PMC6978997

[43] Shi M,Loudig O.Initial development and testing of an exhaled microRNA detection strategy for lung cancer case-control discrimination.Sci Rep2023;13:6620 PMCID:PMC10126132

[44] Pinkerton M,Banta E.Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults.J Allergy Clin Immunol2013;132:217-9

[45] Pérez-Sánchez C,Pantaleão LC.Clinical utility of microRNAs in exhaled breath condensate as biomarkers for lung cancer.J Pers Med2021;11:111 PMCID:PMC7916163

[46] Mendes FC,Ferreira AC.Development and validation of exhaled breath condensate microRNAs to identify and endotype asthma in children.PLoS One2019;14:e0224983 PMCID:PMC6839869

[47] Faversani A,Dioni L.An EBC/Plasma miRNA signature discriminates lung adenocarcinomas from pleural mesothelioma and healthy controls.Front Oncol2021;11:643280 PMCID:PMC8239300

[48] Lucchetti D,Perelli L.Detection and characterisation of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients.Eur Respir J2021;58:2003024

[49] Dobhal G,Ayupova D,Goreham RV.Isolation, characterisation and detection of breath-derived extracellular vesicles.Sci Rep2020;10:17381 PMCID:PMC7566616

[50] Sinha A,Chakraborty S.Exosome-enclosed microRNAs in exhaled breath hold potential for biomarker discovery in patients with pulmonary diseases.J Allergy Clin Immunol2013;132:219-22

[51] O'Brien J,Zayed Y.Overview of MicroRNA biogenesis, mechanisms of actions, and circulation.Front Endocrinol2018;9:402 PMCID:PMC6085463

[52] Ketting RF. microRNA Biogenesis and Function. In: Großhans H, editor. Regulation of microRNAs. New York: Springer US; 2010. pp. 1-14.

[53] Ardekani AM.The role of MicroRNAs in human diseases.Avicenna J Med Biotechnol2010;2:161-79. PMCID:PMC3558168

[54] Acunzo M,Wernicke D.MicroRNA and cancer--a brief overview.Adv Biol Regul2015;57:1-9

[55] Santos RM,Zhang WC.Non-coding RNAs in lung tumor initiation and progression.Int J Mol Sci2020;21:2774 PMCID:PMC7215285

[56] Rohan TE,Weinmann S.A miRNA expression signature in breast tumor tissue is associated with risk of distant metastasis.Cancer Res2019;79:1705-13

[57] Yanaihara N,Bowman E.Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.Cancer Cell2006;9:189-98

[58] Zhu X,Huang X.Frontiers of MicroRNA signature in non-small cell lung cancer.Front Cell Dev Biol2021;9:643942 PMCID:PMC8058364

[59] Chakrabortty A,Smith BF.miRNAs: Potential as biomarkers and therapeutic targets for cancer.Genes2023;14:1375 PMCID:PMC10378777

[60] Ware AP,Chawla A,Satyamoorthy K.Diagnostic and prognostic potential clustered miRNAs in bladder cancer.3 Biotech2022;12:173 PMCID:PMC9279521

[61] Mao S,Zheng S.Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer.J Exp Clin Cancer Res2020;39:193 PMCID:PMC7504642

[62] Quirico L.The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies.Cancer Drug Resist2020;3:117-39 PMCID:PMC9090592

[63] Théry C,Amigorena S.Exosomes: composition, biogenesis and function.Nat Rev Immunol2002;2:569-79

[64] Pitt JM,Zitvogel L.Extracellular vesicles: masters of intercellular communication and potential clinical interventions.J Clin Invest2016;126:1139-43 PMCID:PMC4811136

[65] Mitchell MI.Communicator extraordinaire: extracellular vesicles in the tumor microenvironment are essential local and long-distance mediators of cancer metastasis.Biomedicines2023;11:2534 PMCID:PMC10526527

[66] Brena D,Bond V.Extracellular vesicle-mediated transport: Reprogramming a tumor microenvironment conducive with breast cancer progression and metastasis.Transl Oncol2022;15:101286 PMCID:PMC8636863

[67] Ozawa PMM,Cavalli IJ,de Souza Fonseca Ribeiro EM.Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells.Breast Cancer Res Treat2018;172:713-23 PMCID:PMC6245099

[68] He S,Yu Y.Exosomal miR-499a-5p promotes cell proliferation, migration and EMT via mTOR signaling pathway in lung adenocarcinoma.Exp Cell Res2019;379:203-13

[69] Yang M,Wang X.MiR-93-5p regulates tumorigenesis and tumor immunity by targeting PD-L1/CCND1 in breast cancer.Ann Transl Med2022;10:203 PMCID:PMC8908185

[70] Fabbri M,Calore F.MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response.Proc Natl Acad Sci U S A2012;109:E2110-6 PMCID:PMC3412003

[71] Wong GL,Lo HW.Exosomal MicroRNAs and organotropism in breast cancer metastasis.Cancers2020;12:1827 PMCID:PMC7408921

[72] Zeng Z,Pan Y.Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis.Nat Commun2018;9:5395 PMCID:PMC6300604

[73] Zhong Y,Bian Y.Discovery and validation of extracellular vesicle-associated miRNAs as noninvasive detection biomarkers for early-stage non-small-cell lung cancer.Mol Oncol2021;15:2439-52 PMCID:PMC8410569

[74] Gao S,Liu T.Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma.Cancer Sci2022;113:648-59 PMCID:PMC8819331

[75] Wortzel I,Kenific CM.Exosome-mediated metastasis: communication from a distance.Dev Cell2019;49:347-60

[76] Mitchell MI,Carter CL.Circulating exosome cargoes contain functionally diverse cancer biomarkers: from biogenesis and function to purification and potential translational utility.Cancers2022;14:3350 PMCID:PMC9318395

[77] Couch Y,Di Vizio D.A brief history of nearly EV-erything - The rise and rise of extracellular vesicles.J Extracell Vesicles2021;10:e12144 PMCID:PMC8681215

[78] Logozzi M,Giuliani A.Increased plasmatic levels of PSA-expressing exosomes distinguish prostate cancer patients from benign prostatic hyperplasia: a prospective study.Cancers2019;11:1449 PMCID:PMC6826376

[79] Newman LA,Johnson J,Hopkins AM.Selective isolation of liver-derived extracellular vesicles redefines performance of miRNA biomarkers for non-alcoholic fatty liver disease.Biomedicines2022;10:195 PMCID:PMC8773667

[80] Chiasserini D,Piersma SR.Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.J Proteomics2014;106:191-204

[81] Choudhary I,Paudel K.Vesicular and extravesicular protein analyses from the airspaces of ozone-exposed mice revealed signatures associated with mucoinflammatory lung disease.Sci Rep2021;11:23203 PMCID:PMC8636509

[82] Mimmi S,Rotundo S.SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections.Clin Chem Lab Med2023;61:1518-24

[83] Miranda J,Nair S.Placental exosomes profile in maternal and fetal circulation in intrauterine growth restriction - Liquid biopsies to monitoring fetal growth.Placenta2018;64:34-43

[84] Than UTT,Broadbent JA,Leavesley DI.Deep sequencing micrornas from extracellular membrane vesicles revealed the association of the vesicle cargo with cellular origin.Int J Mol Sci2020;21:1141 PMCID:PMC7036882

[85] Yu H,Cuk K,Zhang Y.Circulating microRNA biomarkers for lung cancer detection in Western populations.Cancer Med2018;7:4849-62 PMCID:PMC6198213

[86] Asakura K,Matsuzaki J.A miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracy.Commun Biol2020;3:134 PMCID:PMC7081195

[87] Vykoukal J,Patel N.Contributions of circulating microRNAs for early detection of lung cancer.Cancers2022;14:4221 PMCID:PMC9454665

[88] Wang X,Lu J.Exosomes and cancer - diagnostic and prognostic biomarkers and therapeutic vehicle.Oncogenesis2022;11:54 PMCID:PMC9477829

[89] He X,Chen Y.Extracellular vesicle-associated miRNAs as a biomarker for lung cancer in liquid biopsy.Front Mol Biosci2021;8:630718 PMCID:PMC7943919

[90] Zhang C,Chen Y.miRNAs derived from plasma small extracellular vesicles predict organo-tropic metastasis of gastric cancer.Gastric Cancer2022;25:360-74

[91] Geng N,Qin W.Two microRNAs of plasma-derived small extracellular vesicles as biomarkers for metastatic non-small cell lung cancer.BMC Pulm Med2023;23:259 PMCID:PMC10347730

[92] Tanaka R,Karouji K.A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology.FEBS Open Bio2023;13:51-9 PMCID:PMC9810119

[93] Kang Y,Suzuki A.Proliferation of human lung cancer in an orthotopic transplantation mouse model.Exp Ther Med2010;1:471-5 PMCID:PMC3445926

[94] Madero-Visbal RA,Hernandez IC.Bioluminescence imaging correlates with tumor progression in an orthotopic mouse model of lung cancer.Surg Oncol2012;21:23-9

[95] Stevens LE,Nguyen DX.Pre-conditioning the airways of mice with bleomycin increases the efficiency of orthotopic lung cancer cell engraftment.J Vis Exp2018;136:56650 PMCID:PMC6102009

[96] Liu Y,Hua Y. A device to collect exhaled breath to study biomarkers in small animal models. Available from: https://www.biorxiv.org/content/10.1101/511931v1.full.pdf+html [Last accessed on 28 Mar 2024]

[97] Mitchell MI,Liu C.Extracellular vesicle capture by AnTibody of CHoice and enzymatic release (EV-CATCHER): a customizable purification assay designed for small-RNA biomarker identification and evaluation of circulating small-EVs.J Extracell Vesicles2021;10:e12110 PMCID:PMC8173589

[98] Loudig O,Rohan T.Retrospective MicroRNA sequencing: complementary DNA library preparation protocol using formalin-fixed paraffin-embedded RNA specimens.J Vis Exp2018;135:57471 PMCID:PMC6101110

[99] Mensà E,Matacchione G.Circulating miR-146a in healthy aging and type 2 diabetes: age- and gender-specific trajectories.Mech Ageing Dev2019;180:1-10

[100] Wu C,Mitchell MI.Coupling suspension trapping-based sample preparation and data-independent acquisition mass spectrometry for sensitive exosomal proteomic analysis.Anal Bioanal Chem2022;414:2585-95 PMCID:PMC9101639

[101] Minn AJ,Siegel PM.Genes that mediate breast cancer metastasis to lung.Nature2005;436:518-24 PMCID:PMC1283098

[102] Agiostratidou G,Suyama K.Loss of retinal cadherin facilitates mammary tumor progression and metastasis.Cancer Res2009;69:5030-8 PMCID:PMC4382672

[103] Kim S,Suyama K.Slug promotes survival during metastasis through suppression of Puma-mediated apoptosis.Cancer Res2014;74:3695-706 PMCID:PMC4437462

[104] Fan J,Chang Z,Yao J.miR-210 transferred by lung cancer cell-derived exosomes may act as proangiogenic factor in cancer-associated fibroblasts by modulating JAK2/STAT3 pathway.Clin Sci2020;134:807-25

[105] Ding J,Zhang Y.Exosome-mediated miR-222 transferring: an insight into NF-κB-mediated breast cancer metastasis.Exp Cell Res2018;369:129-38

[106] Perez SM,Kelly KA.Plectin in cancer: from biomarker to therapeutic target.Cells2021;10:2246 PMCID:PMC8469460

[107] Fei F,Zhang M,Zhang S.S100A4 in cancer progression and metastasis: a systematic review.Oncotarget2017;8:73219-39 PMCID:PMC5641208

[108] Zheng G.Male breast cancer: an updated review of epidemiology, clinicopathology, and treatment.J Oncol2022;2022:1734049 PMCID:PMC9155932

[109] Serganova I,Vider J.Multimodality imaging of TGFbeta signaling in breast cancer metastases.FASEB J2009;23:2662-72 PMCID:PMC2717767

[110] Jenkins DE,Oei Y,Purchio T.Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.Breast Cancer Res2005;7:R444-54 PMCID:PMC1175057

[111] Perry MR,Hawks R.A novel sulfur mustard (HD) vapor inhalation exposure model of pulmonary toxicity for the efficacy evaluation of candidate medical countermeasures.Inhal Toxicol2021;33:221-33 PMCID:PMC8602763

[112] Neuhaus S,Vautz W,Bufe A.Comparison of metabolites in exhaled breath and bronchoalveolar lavage fluid samples in a mouse model of asthma.J Appl Physiol2011;111:1088-95

[113] Jonasson S,Wingfors H.Potential exhaled breath biomarkers identified in chlorine-exposed mice.J Anal Toxicol2024;48:171-9

[114] Paris D,Mirra V.NMR profiling of exhaled breath condensate defines different metabolic phenotypes of non-cystic fibrosis bronchiectasis.Int J Mol Sci2020;21:8600 PMCID:PMC7698311

[115] Kulshreshtha A,Agrawal A.Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation.J Allergy Clin Immunol2013;131:1194-203, 1203.e1-14

[116] Lee H,Zhu Z,Jin Y.Epithelial cell-derived microvesicles activate macrophages and promote inflammation via microvesicle-containing microRNAs.Sci Rep2016;6:35250 PMCID:PMC5059671

[117] Shikano S,Maruoka S.Increased extracellular vesicle miRNA-466 family in the bronchoalveolar lavage fluid as a precipitating factor of ARDS.BMC Pulm Med2019;19:110 PMCID:PMC6584994

[118] Stachowiak Z,Jończyk-Potoczna K,Langwiński W.Extracellular vesicles-derived miRNAs as mediators of pulmonary exacerbation in pediatric cystic fibrosis.J Breath Res2023;17:026005

[119] An J,Kim YK.Extracellular vesicle-derived microbiome obtained from exhaled breath condensate in patients with asthma.Ann Allergy Asthma Immunol2021;126:729-31

[120] Bidola P,Achterhold K.A step towards valid detection and quantification of lung cancer volume in experimental mice with contrast agent-based X-ray microtomography.Sci Rep2019;9:1325 PMCID:PMC6362109

[121] Drosten M,Barbacid M.Genetically engineered mouse models of k-ras-driven lung and pancreatic tumors: validation of therapeutic targets.Cold Spring Harb Perspect Med2018;8:a031542 PMCID:PMC5932580

[122] Fitzgerald B,Cui C.A mouse model for the study of anti-tumor T cell responses in Kras-driven lung adenocarcinoma.Cell Rep Methods2021;1:100080 PMCID:PMC8500377

[123] Foggetti G,Cai H.Genetic determinants of EGFR-driven lung cancer growth and therapeutic response in vivo.Cancer Discov2021;11:1736-53 PMCID:PMC8530463

[124] Politi K,Shen R,Varmus H.Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma.Dis Model Mech2010;3:111-9 PMCID:PMC2806903

[125] Ramelow J,Gao L.The oncogenic potential of a mutant TP53 gene explored in two spontaneous lung cancer mice models.BMC Cancer2020;20:738 PMCID:PMC7414707

[126] Abdolahi S,Muhammadnejad S,Asadzadeh Aghdaei H.Patient-derived xenograft (PDX) models, applications and challenges in cancer research.J Transl Med2022;20:206 PMCID:PMC9088152

[127] Chiappetta M,Congedo MT.Management of single pulmonary metastases from colorectal cancer: state of the art.World J Gastrointest Oncol2022;14:820-32 PMCID:PMC9048528

[128] Jin L,Siegel E,Giuliano A.Breast cancer lung metastasis: Molecular biology and therapeutic implications.Cancer Biol Ther2018;19:858-68 PMCID:PMC6300341

[129] Tyagi A,Wu K.Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung.Nat Commun2021;12:474 PMCID:PMC7817836

[130] Patel HD,Ghandour RA.Site of extranodal metastasis impacts survival in patients with testicular germ cell tumors.Cancer2019;125:3947-52 PMCID:PMC6819223

[131] Zhang J,Singh A.Complete regression of lung metastases in a patient with metastatic castration-resistant prostate cancer using ¹⁷⁷Lu-PSMA radioligand therapy.Clin Nucl Med2020;45:e48-50

[132] Gardner AB,Mann AK,Eskander RN.Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.Clin Exp Metastasis2020;37:107-13